Low Lung Function Is Associated with High Population Attributable Fraction for Cardiovascular Mortality
- PMID: 39447115
- PMCID: PMC11892675
- DOI: 10.1513/AnnalsATS.202407-715OC
Low Lung Function Is Associated with High Population Attributable Fraction for Cardiovascular Mortality
Abstract
Rationale: Chronic lung diseases are associated with increased risk of mortality due to coronary heart disease (CHD). Nonetheless, the population attributable fraction (PAF) of lung function impairment relative to other established cardiovascular risk factors is unclear. Objectives: To evaluate the PAF of low lung function for CHD mortality Methods: We harmonized and pooled lung function and clinical data across eight U.S. general population cohorts. Impaired lung function was defined as forced expiratory volume in 1 second (FEV1) and/or forced vital capacity ≤ 95% predicted on baseline spirometry. The association between CHD mortality and risk factors was assessed using cause-specific proportional hazards and Fine-Gray proportional subdistribution hazard models, treating non-CHD mortality as a competing risk. Models were adjusted for lung function as well as age, sex, race/ethnicity, educational attainment, body mass index, smoking status, pack-years of smoking, diabetes mellitus, high-density lipoprotein, and high low-density lipoprotein (≥130 mg/dl). PAF was calculated as the relative change in the average absolute risk of 10-year CHD mortality by elimination of lung function lower than 95% predicted. Results: Among 35,143 participants, 1,844 of 13,174 (14.0%) deaths were due to CHD. Compared with percentage predicted FEV1 (FEV1pp) > 95%, the subdistribution adjusted hazard ratio for low FEV1pp was 1.30 (95% confidence interval, 1.18-1.44). The PAF for FEV1pp ≤ 95% was 12%, ranking low FEV1 third on the list of PAF for CHD mortality, after hypertension and diabetes. Low FEV1pp ranked second in the subgroup of active smokers (PAF 14%), after hypertension. Conclusions: Low lung function, even in the range considered clinically normal, ranks high on the list of attributable risk factors for CHD mortality and should be considered in cardiovascular risk stratification.
Keywords: coronary heart disease; lung function; population attributable fraction.
References
-
- Sidney S, Quesenberry CP, Jr, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol . 2016;1:594–599. - PubMed
-
- Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham study. Am J Cardiol . 1976;38:46–51. - PubMed
-
- Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Sr, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol . 2014;63:2935–2959. - PMC - PubMed
-
- Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med . 2015;3:631–639. - PubMed
MeSH terms
Grants and funding
- 75N92023D00005/GF/NIH HHS/United States
- U01 HL041654/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- 75N92023D00004/HL/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- R01 HL109315/HL/NHLBI NIH HHS/United States
- R01 HL151421/HL/NHLBI NIH HHS/United States
- N01 HC085080/HL/NHLBI NIH HHS/United States
- HHSN268201800012I/HB/NHLBI NIH HHS/United States
- HHSN268201800012C/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- U01 HL041642/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- 75N92023D00005/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC085082/HL/NHLBI NIH HHS/United States
- HHSN268201800014I/HB/NHLBI NIH HHS/United States
- HHSN268201700004C/HB/NHLBI NIH HHS/United States
- U01 HL130114/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- RC1 HL100543/HL/NHLBI NIH HHS/United States
- U01 HL041652/HL/NHLBI NIH HHS/United States
- HHSN268201800014C/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- R01 NR012459/NR/NINR NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- HHSN268201700001I/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- HHSN268201800013I/MD/NIMHD NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- HHSN268201700004I/HL/NHLBI NIH HHS/United States
- R21 HL165405/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- R21 HL129924/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- R01 HL109319/HL/NHLBI NIH HHS/United States
- 75N92023D00002/HL/NHLBI NIH HHS/United States
- R01 AG028050/AG/NIA NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- HHSN268201800011C/HL/NHLBI NIH HHS/United States
- R01 HL109284/HL/NHLBI NIH HHS/United States
- HHSN268201700005C/HL/NHLBI NIH HHS/United States
- HHSN268201700001C/HL/NHLBI NIH HHS/United States
- HHSN268201700002C/HB/NHLBI NIH HHS/United States
- HHSN268201700003C/HL/NHLBI NIH HHS/United States
- U01 HL065521/HL/NHLBI NIH HHS/United States
- HHSN268201800015I/HB/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- HHSN268201700002I/HL/NHLBI NIH HHS/United States
- R01 HL155576/HL/NHLBI NIH HHS/United States
- HHSN268201800010I/HB/NHLBI NIH HHS/United States
- HHSN268201700005I/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- K23 HL130627/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- HHSN268201800011I/HB/NHLBI NIH HHS/United States
- 75N92023D00002/GF/NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- R01 HL109301/HL/NHLBI NIH HHS/United States
- 75N92023D00003/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- HHSN268201700003I/HL/NHLBI NIH HHS/United States
- R01 HL109282/HL/NHLBI NIH HHS/United States
- N01 HC085081/HL/NHLBI NIH HHS/United States
- U01 HL065520/HL/NHLBI NIH HHS/United States
- R01 HL157634/HL/NHLBI NIH HHS/United States
- 75N92023D00004/GF/NIH HHS/United States
- R21 HL156228/HL/NHLBI NIH HHS/United States
- 75N92023D00006/HL/NHLBI NIH HHS/United States
- UH3 HL155806/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous